Heart Test Laboratories, Inc.
HSCS • NASDAQ
Heart Test Laboratories, Inc. is a medical - devices company in the healthcare sector trading on NASDAQ, led by CEO Andrew Simpson, with a market cap of $7.2M.
CEOAndrew Simpson
Next Earnings
No upcoming earnings scheduled for Heart Test Laboratories, Inc.
No earnings announcement scheduled
Earnings History
Past 12 earnings reports for Heart Test Laboratories, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 16, 2026 | Q3 2026 | -$0.63Est: -$1.12 | +43.8% | -Est: $200.0K | -100.0% |  10-Q |
| Dec 15, 2025 | Q2 2026 | -$0.85Est: -$1.12 | +24.1% | $2.4KEst: $50.0K | -95.2% | 10-Q |
| Sep 11, 2025 | Q1 2026 | -$1.58Est: -$2.09 | +24.4% | $1.9M | — | 10-Q |
| Jul 24, 2025 | Q4 2025 | -$1.86Est: -$2.29 | +18.8% | $4.4MEst: - | — | 10-K |
| Mar 13, 2025 | Q3 2025 | -$2.57Est: -$2.08 | -23.6% | - | — | 10-Q |
| Dec 16, 2024 | Q2 2025 | -$2.27Est: -$2.43 | +6.6% | -Est: $500.0K | -100.0% | 10-Q |
| Sep 12, 2024 | Q1 2025 | -$2.64Est: -$2.43 | -8.6% | -Est: $350.0K | -100.0% | 10-Q |
| Jul 29, 2024 | Q4 2024 | $0.00Est: -$3.00 | +100.0% | -Est: $200.0K | -100.0% | 10-K |
| Mar 14, 2024 | Q3 2024 | -$3.00Est: -$6.00 | +50.0% | $14.7K | — | 10-Q |
| Dec 14, 2023 | Q2 2024 | -$16.00Est: -$12.00 | -33.3% | $3.9K | — | — |
| Sep 14, 2023 | Q1 2024 | -$13.00Est: -$14.00 | +7.1% | - | — | 10-Q |
| Jul 19, 2023 | Q4 2023 | -$16.00Est: -$16.00 | 0.0% | - | — | — |